Keywords: ofatumumab, patients, reach, acr, uk, drug, major

46% of ofatumumab patients reach ACR 20

Article | 25 June 2007

Print This

UK drug major GlaxoSmithKline and Denmark's Genmab AS reported positive primary efficacy data at the 2007 meeting of the European League ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in